146 related articles for article (PubMed ID: 21434951)
41. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor.
Reimer C; Lødrup AB; Smith G; Wilkinson J; Bytzer P
Aliment Pharmacol Ther; 2016 Apr; 43(8):899-909. PubMed ID: 26909885
[TBL] [Abstract][Full Text] [Related]
42. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.
Pouchain D; Bigard MA; Liard F; Childs M; Decaudin A; McVey D
BMC Gastroenterol; 2012 Feb; 12():18. PubMed ID: 22361121
[TBL] [Abstract][Full Text] [Related]
43. The suppression of gastro-oesophageal reflux by alginates.
Dettmar PW; Hampson FC; Taubel J; Lorch U; Johnstone LM; Sykes J; Berry PJ
Int J Clin Pract; 2007 Oct; 61(10):1654-62. PubMed ID: 17681004
[TBL] [Abstract][Full Text] [Related]
44. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.
Zentilin P; Dulbecco P; Savarino E; Parodi A; Iiritano E; Bilardi C; Reglioni S; Vigneri S; Savarino V
Aliment Pharmacol Ther; 2005 Jan; 21(1):29-34. PubMed ID: 15644042
[TBL] [Abstract][Full Text] [Related]
45. A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.
Giannini EG; Zentilin P; Dulbecco P; Iiritano E; Bilardi C; Savarino E; Mansi C; Savarino V
Dig Dis Sci; 2006 Nov; 51(11):1904-9. PubMed ID: 16977507
[TBL] [Abstract][Full Text] [Related]
46. [Esophageal reflux and peptic ulcer. An exclusive advanced education service of the Gastro-Liga for family physicians].
Fortschr Med; 1998 Dec; 116(34):35-8. PubMed ID: 10024760
[No Abstract] [Full Text] [Related]
47. GERD: Alginate rafts localize to the acid pocket and reduce acid reflux in GERD.
Leake I
Nat Rev Gastroenterol Hepatol; 2013 Jul; 10(7):386. PubMed ID: 23712315
[No Abstract] [Full Text] [Related]
48. [Therapeutic procedures in gastroesophageal reflux disease].
Tytgat GN
Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
[TBL] [Abstract][Full Text] [Related]
49. [Gaviscon in reflux symptoms. Results of a drug monitoring study].
Hutt HJ; Tauber O; Flach D
Fortschr Med; 1990 Oct; 108(31):598-600. PubMed ID: 2258131
[TBL] [Abstract][Full Text] [Related]
50. Oesophageal disease in the elderly.
Pelemans W; Vantrappen G
Clin Gastroenterol; 1985 Oct; 14(4):635-56. PubMed ID: 2867841
[No Abstract] [Full Text] [Related]
51. Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid.
Castell DO; Dalton CB; Becker D; Sinclair J; Castell JA
Dig Dis Sci; 1992 Apr; 37(4):589-93. PubMed ID: 1551350
[TBL] [Abstract][Full Text] [Related]
52. [Update on gastroesophageal reflux disease].
Serra Pueyo J
Gastroenterol Hepatol; 2014 Feb; 37(2):73-82. PubMed ID: 24355558
[TBL] [Abstract][Full Text] [Related]
53. Patterns of food and acid reflux in patients with low-grade oesophagitis--the role of an anti-reflux agent.
Washington N; Steele RJ; Jackson SJ; Washington C; Bush D
Aliment Pharmacol Ther; 1998 Jan; 12(1):53-8. PubMed ID: 9692701
[TBL] [Abstract][Full Text] [Related]
54. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.
Buts JP; Barudi C; Otte JB
Eur J Pediatr; 1987 Mar; 146(2):156-8. PubMed ID: 3032640
[TBL] [Abstract][Full Text] [Related]
55. An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy.
Lindow SW; Regnéll P; Sykes J; Little S
Int J Clin Pract; 2003 Apr; 57(3):175-9. PubMed ID: 12723718
[TBL] [Abstract][Full Text] [Related]
56. Gaviscon: not always entirely safe!
Shenvi A
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23329718
[No Abstract] [Full Text] [Related]
57. [Alginate improves symptom control].
Siegmund-Schultze N
MMW Fortschr Med; 2016 Jun; 158(11):76. PubMed ID: 27271425
[No Abstract] [Full Text] [Related]
58. In-vivo anti-reflux and raft properties of alginates.
Lambert JR; Korman MG; Nicholson L; Chan JG
Aliment Pharmacol Ther; 1990 Dec; 4(6):615-22. PubMed ID: 2129648
[TBL] [Abstract][Full Text] [Related]
59. [Gaviscon].
Ménégol-Couque B; Brard M
Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
[No Abstract] [Full Text] [Related]
60. Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon® Advance: how we do it.
Lieder A; Issing W
Clin Otolaryngol; 2011 Dec; 36(6):583-7. PubMed ID: 22212545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
